Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome.
about
Guillain-Barré syndrome and variantsNeuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?Neuro-glial interactions at the nodes of Ranvier: implication in health and diseasesNode of Ranvier disruption as a cause of neurological diseasesMolecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+/third FNIII domain-) and NrCAM at nodal axon segmentsElectron tomographic analysis of cytoskeletal cross-bridges in the paranodal region of the node of Ranvier in peripheral nerves.Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.Are anti-ganglioside antibodies associated with proventricular dilatation disease in birds?New concepts of Guillain-Barré syndrome.Campylobacter species and Guillain-Barré syndrome.Identification of gene networks and pathways associated with Guillain-Barré syndrome.An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome.Axonal Guillain-Barré syndrome: a critical review.Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder.Treatment guidelines for Guillain-Barré Syndrome.Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation.Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies.Two unusual variants of Guillain-Barre syndrome.Anti-ganglioside antibodies alter presynaptic release and calcium influxGuillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey.An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction.Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome.Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.An update in guillain-barré syndromeAntiganglioside antibodies in Guillain-Barré syndrome and its related conditions.The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy.Recent developments and future directions in Guillain-Barré syndrome.Natura non facit saltus in anti-ganglioside antibody-mediated neuropathies.Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.Guillain-Barré syndrome in Asia.Nodopathies of the peripheral nerve: an emerging concept.Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin.Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy.Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.Guillain-Barré syndrome: a century of progress.Acute Motor Axonal Neuropathy (Aman) With Motor Conduction Blocks In Childhood; Case Report.An electrophysiological classification associated with Guillain-Barré syndrome outcomes.Intravenous IgG in Guillain-Barré syndrome.Guillain-Barré syndrome in the 100 years since its description by Guillain, Barré and Strohl.
P2860
Q22252353-43BA7A1E-CC36-4BA7-B1B2-4400F8C05442Q26801349-C8790A25-E86F-4099-A588-A6745A8CD5F7Q26825224-F6D91AE9-8C22-4104-858D-158798E1F99BQ27009974-394E2E0C-03A9-485F-8096-4DB27DA69D1EQ28566036-2BB665EA-9D73-4414-8D8D-3B6D404AC817Q30481786-D5524401-4903-4631-85BD-BC1038680EE6Q30827235-2BDB6A86-11E3-4246-99FE-608CAF322CACQ33561954-4E5AC223-7FFD-477A-9A55-05AC8088D406Q33886911-BAB22524-4387-4AC1-AF43-0A6C8B7C4600Q33975353-F00D5A55-89B5-4976-ABB0-F7DCE0E5D2B1Q34130447-BF637ADA-7830-4F8A-A836-74B7E5765D6BQ34167468-F033325F-8145-43DA-AFC6-808BE51A7A77Q34235801-20C031CA-92EF-456C-901B-71E0702B2C4DQ34443138-F5DEEF13-5E3A-49DC-87BB-80B189CE85A5Q35152989-0DE023C7-C2F1-4515-988A-9AB7E7D5EB8CQ35547885-1ADCE885-41D5-45EF-87B0-8C2F535DCEEEQ35713309-39802C63-FDE2-479A-A883-FB6F9B578B29Q35982444-0E7DF752-B7DD-48E4-9D1C-964DFA97863FQ36168575-17A53E5F-168B-43F8-9B36-2F8851D0C0D7Q36174702-11817D8D-2BCC-4D2C-81CF-3DF57623E4C4Q36328448-0D44379E-9A07-4FD0-B337-4FFF9DB06EE4Q36896911-F286093F-4572-4EA7-899B-D5CCA6BA43AAQ37207391-F4998670-93CD-4E8B-8C14-A2D3C995B6D8Q37544140-481B6A48-93D0-4605-8886-12F3614452A4Q37921765-A62ED69B-D8E7-4324-A05A-1D6F084E09C9Q38070878-36D33C99-E708-4421-9CC9-11D70597B24FQ38070887-AD927320-8C54-4F4F-AC82-2BFA0C8A58B6Q38102612-29AEDFF2-2978-4F28-84A5-74C387ABDF2DQ38137792-B64202E8-BCE2-46D1-B216-A54DE3839EFCQ38172906-072675DA-BC9D-4686-9704-4FB3B25EB1F6Q38362776-78461B9F-7E79-40DE-BC91-77F3DFB68992Q38605062-E8E07DC2-5ADC-43A1-B779-099A675ABE6BQ38633484-A44B21AA-2C8B-4F55-B1C7-68DBE57E9937Q38748904-AEE3E41F-BA4F-479F-B2E8-6F7C7A0DAB30Q38868347-AE07A399-AECA-42C6-A7E8-CC08AD2F5975Q39011456-283ADC2B-7289-45B5-8857-AAFA1370EF6FQ39726772-4DF244D2-DB0D-47CD-8826-5A67578D5A42Q42203555-B09A2D57-0AB5-402B-BC03-C75563B21D37Q42721886-1EFF349D-7915-4CCE-A8B2-6D62E67F7703Q43046804-480183A2-939E-46BF-8126-D9E5193DC8B8
P2860
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Early nodal changes in the acu ...... f the Guillain-Barré syndrome.
@en
Early nodal changes in the acu ...... f the Guillain-Barré syndrome.
@nl
type
label
Early nodal changes in the acu ...... f the Guillain-Barré syndrome.
@en
Early nodal changes in the acu ...... f the Guillain-Barré syndrome.
@nl
prefLabel
Early nodal changes in the acu ...... f the Guillain-Barré syndrome.
@en
Early nodal changes in the acu ...... f the Guillain-Barré syndrome.
@nl
P2093
P2860
P356
P1476
Early nodal changes in the acu ...... f the Guillain-Barré syndrome.
@en
P2093
Cornblath DR
Griffin JW
McKhann GM
P2860
P356
10.1007/BF02284784
P50
P577
1996-01-01T00:00:00Z